Anti-Müllerian hormone as a predictor of IVF treatment

Anti-Müllerian Hormone (AMH) is secreted from granulosa cells of growing follicles and is a useful marker of ovarian reserve. Fertility in women is determined by the quality and quantity of follicle pool and ovarian follicular reserve positively correlates with AMH. In this study we aimed to determine if AMH can predict ovarian response in IVF treatments. In this retrospective observational study undertaken in Mehr Institute during 2010 to 2011، we studied the medical records of 101 patients and recorded the concentrations of AMH، day two or three FSH، LH، basal estradiol (E2)، E2 on day of HCG administration and the number of metaphase II oocytes. Having undergone ovarian hyperstimulation، the women were divided into three groups: poor responders (retrieved oocytes? 3)، normal responders (retrieved oocytes 4 to 15) and high responders (retrieved oocytes? 16). Overall، 20% of patients were defined as poor responders، 71% as average responders and 10% as high responders. There were significant differences in the concentration of AMH، E2 on day of HCG administration، FSH، the number of metaphase II oocytes and age between the three groups. MII oocyte count correlated positively with AMH (r=0. 487)، basal E2 (r=0. 275) and LH (r=0. 07) but it did negatively with FSH (r=-0. 26) and age (r=-0. 04). The areas under curve for AMH، FSH، LH، E2 and age were 0. 799، 0. 32، 0. 429، 0. 558 and 0. 304، respectively. We determined the 0. 85 ng/ml AMH concentration as the cut-off point with 71% specificity and 79% sensitivity for the prediction of poor responders. anti-müllerian hormone is an appropriate predicator of ovarian response following induction of ovulation.